CDKN3 and breast cancer: Moreover, eugenol prevented various oncogenes-related breast cancer namely, NF-κB and cyclin D1 as well as blocked the breast cancer multiplication in a p53- independent manner and upregulated the flexible cyclin-dependent kinase inhibitor protein and this anti-proliferative activity was significantly noticed in xenograft human breast tumors.